New Diet Pill Excalia™ to Help You with Weight Loss!
Orexigen Therapeutics has come up with a new weight loss pill that is currently working it's way through clinical trials. In a Phase 2 clinical trial that took place in 2004, Excalia™ produced more than a 8% mean weight loss at 16 weeks and more than 9% at 24 weeks.
Excalia™ is a combination of zonisamide IR plus and bupropion SR. Further clinical trials are underway to help determine the best ratios of the drugs. IR means Immediate Release and SR means Sustained Release.
Excalia™ seems to work in two ways...first gives you a sense of fullness and also raises your metabolism rate to increase energy usage. While people are not being requested at the moment to take part in Excalia™ clinical trials, you can get more information about them at http://www.clinicaltrials.gov.
Since Excalia™ is still in trials and has not been approved by the FDA, the drug is not yet available in the United States.
Technorati Tags: Excalia Diet Pill Weight Loss Weight Loss PillLose Weight Zonisamide Bupropion
Orexigen Therapeutics has come up with a new weight loss pill that is currently working it's way through clinical trials. In a Phase 2 clinical trial that took place in 2004, Excalia™ produced more than a 8% mean weight loss at 16 weeks and more than 9% at 24 weeks.
Excalia™ is a combination of zonisamide IR plus and bupropion SR. Further clinical trials are underway to help determine the best ratios of the drugs. IR means Immediate Release and SR means Sustained Release.
Excalia™ seems to work in two ways...first gives you a sense of fullness and also raises your metabolism rate to increase energy usage. While people are not being requested at the moment to take part in Excalia™ clinical trials, you can get more information about them at http://www.clinicaltrials.gov.
Since Excalia™ is still in trials and has not been approved by the FDA, the drug is not yet available in the United States.
Technorati Tags: Excalia Diet Pill Weight Loss Weight Loss PillLose Weight Zonisamide Bupropion
posted by Ken MacKenzie @ 4:02 PM
0 comments
